Literature DB >> 21297608

Stemming a tumor with a little miR.

Max S Wicha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21297608     DOI： 10.1038/nm0211-162

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

1.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing.

Authors:  Andrew Grimson; Kyle Kai-How Farh; Wendy K Johnston; Philip Garrett-Engele; Lee P Lim; David P Bartel
Journal:  Mol Cell       Date:  2007-07-06       Impact factor: 17.970

2.  Targeting of CD44 eradicates human acute myeloid leukemic stem cells.

Authors:  Liqing Jin; Kristin J Hope; Qiongli Zhai; Florence Smadja-Joffe; John E Dick
Journal:  Nat Med       Date:  2006-09-24       Impact factor: 53.440

Review 3.  MicroRNAs, cancer and cancer stem cells.

Authors:  Amy L Zimmerman; Shiyong Wu
Journal:  Cancer Lett       Date:  2010-10-20       Impact factor: 8.679

Review 4.  Targeting stem cells-clinical implications for cancer therapy.

Authors:  Lan Chun Tu; Greg Foltz; Edward Lin; Leroy Hood; Qiang Tian
Journal:  Curr Stem Cell Res Ther       Date:  2009-05       Impact factor: 3.828

5.  Cancer stem cells: an old idea--a paradigm shift.

Authors:  Max S Wicha; Suling Liu; Gabriela Dontu
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

6.  Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.

Authors:  Xiaoxian Li; Michael T Lewis; Jian Huang; Carolina Gutierrez; C Kent Osborne; Meng-Fen Wu; Susan G Hilsenbeck; Anne Pavlick; Xiaomei Zhang; Gary C Chamness; Helen Wong; Jeffrey Rosen; Jenny C Chang
Journal:  J Natl Cancer Inst       Date:  2008-04-29       Impact factor: 13.506

7.  TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis.

Authors:  Gustavo Pacheco-Rodriguez; Wendy K Steagall; Denise M Crooks; Linda A Stevens; Hiroshi Hashimoto; Shaowei Li; Ji-an Wang; Thomas N Darling; Joel Moss
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

8.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal:  Nat Med       Date:  2011-01-16       Impact factor: 53.440

9.  A luminal epithelial stem cell that is a cell of origin for prostate cancer.

Authors:  Xi Wang; Marianna Kruithof-de Julio; Kyriakos D Economides; David Walker; Hailong Yu; M Vivienne Halili; Ya-Ping Hu; Sandy M Price; Cory Abate-Shen; Michael M Shen
Journal:  Nature       Date:  2009-09-09       Impact factor: 49.962

10.  CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts.

Authors:  E Marangoni; N Lecomte; L Durand; G de Pinieux; D Decaudin; C Chomienne; F Smadja-Joffe; M-F Poupon
Journal:  Br J Cancer       Date:  2009-02-24       Impact factor: 7.640
View more
  4 in total

1.  miR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A.

Authors:  Ling Chen; Hong Xiao; Zong-Hua Wang; Yi Huang; Zi-Peng Liu; Hui Ren; Hang Song
Journal:  BMB Rep       Date:  2014-01       Impact factor: 4.778

2.  Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer.

Authors:  Gabriel Schmid; Sara Notaro; Daniel Reimer; Samira Abdel-Azim; Michaela Duggan-Peer; Jessica Holly; Heidi Fiegl; Julia Rössler; Annemarie Wiedemair; Nicole Concin; Peter Altevogt; Christian Marth; Alain Gustave Zeimet
Journal:  BMC Cancer       Date:  2016-02-15       Impact factor: 4.430

3.  MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer.

Authors:  N Bucay; K Sekhon; T Yang; S Majid; V Shahryari; C Hsieh; Y Mitsui; G Deng; Z L Tabatabai; S Yamamura; G A Calin; R Dahiya; Y Tanaka; S Saini
Journal:  Oncogene       Date:  2016-11-28       Impact factor: 9.867

Review 4.  MicroRNAs and epithelial-mesenchymal transition in prostate cancer.

Authors:  Kirandeep Sekhon; Nathan Bucay; Shahana Majid; Rajvir Dahiya; Sharanjot Saini
Journal:  Oncotarget       Date:  2016-10-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.